Due to the high Ki67 index, the high number of mitoses, and the extremely strong expression of p53 in the nuclei, both tumors in this study differ from pituitary carcinomas described in the literature and in the 2017 WHO classification [12]. This evidence concerns the gene TP53 and pituitary adenocarcinoma.